The estimated Net Worth of Robert E. Waltermire is at least $1.96 million dollars as of 14 June 2024. Dr Waltermire owns over 1,900 units of Madrigal Pharmaceuticals Inc stock worth over $1,724,200 and over the last 3 years he sold MDGL stock worth over $239,668.
Sign up
Dr D MDGL stock SEC Form 4 insiders trading
Dr has made over 6 trades of the Madrigal Pharmaceuticals Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 1,900 units of MDGL stock worth $165,471 on 14 June 2024.
The largest trade he's ever made was exercising 10,000 units of Madrigal Pharmaceuticals Inc stock on 28 February 2023 worth over $879,200. On average, Dr trades about 2,067 units every 43 days since 2021. As of 14 June 2024 he still owns at least 7,400 units of Madrigal Pharmaceuticals Inc stock.
You can see the complete history of Dr Waltermire stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Robert E. Waltermire Ph.D. biography
Dr. Robert E. Waltermire Ph.D. is the Chief Pharmaceutical Devel. Officer at Madrigal Pharmaceuticals Inc.
How old is Dr D?
Dr D is 57, he's been the Chief Pharmaceutical Devel. Officer of Madrigal Pharmaceuticals Inc since . There are 13 older and 4 younger executives at Madrigal Pharmaceuticals Inc. The oldest executive at Madrigal Pharmaceuticals Inc is David Milligan, 79, who is the Independent Director.
What's Dr D's mailing address?
Robert's mailing address filed with the SEC is C/O MADRIGAL PHARMACEUTICALS, INC., 200 BARR HARBOR DRIVE, SUITE 200, WEST CONSHOHOCKEN, PA, 19428.
Insiders trading at Madrigal Pharmaceuticals Inc
Over the last 8 years, insiders at Madrigal Pharmaceuticals Inc have traded over $471,222,585 worth of Madrigal Pharmaceuticals Inc stock and bought 443,785 units worth $79,114,183 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Paul A Friedman et Bros. Advisors Lp667, L.P.B.... On average, Madrigal Pharmaceuticals Inc executives and independent directors trade stock every 56 days with the average trade being worth of $20,602,093. The most recent stock trade was executed by William John Sibold on 9 September 2024, trading 6,363 units of MDGL stock currently worth $1,551,490.
What does Madrigal Pharmaceuticals Inc do?
madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.
What does Madrigal Pharmaceuticals Inc's logo look like?
Complete history of Dr Waltermire stock trades at Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc executives and stock owners
Madrigal Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Paul Friedman,
Chairman of the Board, Chief Executive Officer -
Rebecca Taub,
President of Research and Development, Chief Medical Officer, Director -
Brian Lynch,
Senior Vice President, General Counsel -
Marc Schneebaum,
Chief Financial Officer, Senior Vice President -
James Daly,
Independent Director -
Dr. Paul A. Friedman M.D.,
Chairman & CEO -
Dr. Rebecca A. Taub M.D.,
Founder, Chief Medical Officer, Pres of R&D and Director -
Remy Sukhija,
Sr. VP & Chief Commercial Officer -
Brian J. Lynch J.D.,
Sr. VP & Gen. Counsel -
Brian J. Lynch,
Sr. VP & Gen. Counsel -
Kenneth Bate,
Independent Director -
Richard Levy,
Independent Director -
Keith Gollust,
Independent Director -
David Milligan,
Independent Director -
Frederick Craves,
Lead Independent Director -
Remy Sukhija,
Senior Vice President, Chief Commercial Officer -
Edward Chiang,
Sr. VP of Clinical & Technical Operations -
Dr. Stephen Dodge M.B.A., Pharm.D.,
Sr. VP & Global Head of Medical Affairs -
Dr. Robert E. Waltermire Ph.D.,
Chief Pharmaceutical Devel. Officer -
Thomas W. Hare,
Sr. VP of Clinical Management -
Dr. Kianoush Motesharei Ph.d.,
Sr. VP of Bus. & Corp. Devel. -
Alex G. Howarth,
Chief Financial Officer -
Bros. Advisors Lp667, L.P.B...,
-
Bros. Advisors Lp667, L.P.B...,
-
Chen Schor,
Former President and CEO -
Wendy E Rieder,
Former SVP, Gen. Counsel -
City Capital Llc Bay,
Director -
City Capital Llc Bay City C...,
-
Alex G. Howarth,
Chief Financial Officer -
Robert E. Waltermire,
Senior VP, Chief Pharma Dev. -
Bros. Advisors Lp Baker,
-
Shannon T Kelley,
General Counsel -
William John Sibold,
President and CEO -
Carole Huntsman,
Chief Commercial Officer -
Fred B Craves,